Tsubata, Yukari http://orcid.org/0000-0002-4260-2849
Kawakado, Keita
Hamai, Kosuke
Furuya, Naoki
Yokoyama, Toshihide
Saito, Ryota
Nakamura, Atsushi
Masuda, Takeshi
Hamaguchi, Megumi
Kuyama, Shoichi
Honda, Ryoichi
Senoo, Tadashi
Nakanishi, Masamoto
Hotta, Takamasa
Yamasaki, Masahiro
Ishikawa, Nobuhisa
Fujitaka, Kazunori
Kubota, Tetsuya
Kobayashi, Kunihiko
Isobe, Takeshi
Funding for this research was provided by:
Daiichi Sankyo Company (LIX-MD-15003)
Article History
Received: 15 May 2022
Accepted: 16 October 2022
First Online: 10 November 2022
Declarations
:
: Yukari Tsubata received grant and personal fees from Daiichi Sankyo Co., Ltd. and AstraZeneca K.K. and personal fees from Chugai Pharmaceuticals Inc. outside the submitted work. Naoki Furuya received personal fees from AstraZeneca K.K., Chugai Pharmaceutical, Nippon Boehringer Ingelheim Co., Ltd., Bristol-Myers Squibb Company, Eli Lilly Japan K.K., MSD K.K., Pfizer Japan Inc. Taiho Pharmaceutical, and Novartis Pharma K.K. outside the submitted work. Toshihide Yokoyama received personal fees from Eli Lilly Japan K.K., Merck Sharp & Dohme K.K., Takeda Pharmaceutical outside the submitted work. Atsushi Nakamura received grant and personal fees from AstraZeneca K.K., Thermo Fisher Scientific, Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K.K., Pfizer Japan Inc., Nippon Boehringer Ingelheim Co., Ltd., and personal fees from Taiho Pharmaceutical Co., Ltd., outside the submitted work. Takeshi Masuda received personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Eli Lilly Japan, Nippon Boehringer Ingelheim Co., Ltd., Kyowa Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., outside the submitted work. Kazunori Fujitaka received personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company, MSD K.K., Pfizer Japan Inc., Daiichi Sankyo Co., Ltd., Eli Lilly Japan, and Nippon Boehringer Ingelheim Co., Ltd. outside the submitted work. Kunihiko Kobayashi received personal fees from AstraZeneca K.K., Takeda Pharmaceutical outside the submitted work. Takeshi Isobe received grant and personal fees from Daiichi Sankyo Co., Ltd., personal fees from AstraZeneca K.K., Pfizer Japan Inc., and Nippon Boehringer Ingelheim Co., Ltd., and grants from Pearl Therapeutics Inc. and Janssen Pharmaceutical K.K. outside the submitted work.